Literature DB >> 30005756

Informing a priori Sample Size Estimation in Qualitative Concept Elicitation Interview Studies for Clinical Outcome Assessment Instrument Development.

Diane M Turner-Bowker1, Roger E Lamoureux2, Jonathan Stokes2, Leighann Litcher-Kelly2, Nina Galipeau2, Andrew Yaworsky2, Jeffrey Solomon3, Alan L Shields2.   

Abstract

OBJECTIVE: Evidence-based recommendations for the a priori estimation of sample size are needed for qualitative concept elicitation (CE) interview studies in clinical outcome assessment (COA) instrument development. Saturation is described as the point at which no new data is expected to emerge from the conduct of additional qualitative interviews. STUDY
DESIGN: A retrospective evaluation of 26 CE interview studies conducted with patients between 2006 and 2013 was completed to assess the point at which saturation of concept was achieved in each study.
METHODS: For each of the 26 interview studies, saturation of symptom concepts was assessed by dividing the sample into quartiles and then comparing the number of responses elicited from the first 25% of participants to the next 25% of participants, from the first 50% of participants to the next 25% of participants, and then from the first 75% of participants to the last 25% of participants. The number of interviews required to achieve saturation was documented for each study and then summarized across studies.
RESULTS: Findings indicate that 84% of symptom concepts emerged by the 10th interview, 92% emerged by the 15th interview, 97% emerged by the 20th interview, and 99% by the 25th interview.
CONCLUSIONS: Results provide practical guidance for estimating the number of interviews that may be needed to achieve saturation in a qualitative CE interview study for COA instrument development; address an important gap in qualitative research for the development of COAs in the context of medical product development; and offer useful information for study design and implementation.
Copyright © 2018 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  clinical outcome assessment; concept elicitation interview; sample size; saturation of concept

Mesh:

Year:  2018        PMID: 30005756     DOI: 10.1016/j.jval.2017.11.014

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  36 in total

1.  Barriers to conducting cancer trials in Canada: an analysis of key informant interviews.

Authors:  C Bentley; S Sundquist; J Dancey; S Peacock
Journal:  Curr Oncol       Date:  2020-06-01       Impact factor: 3.677

2.  The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer.

Authors:  Andrea Bever; Jackie Manthorne; Tissa Rahim; Layla Moumin; Shelagh M Szabo
Journal:  Patient       Date:  2021-10-13       Impact factor: 3.883

3.  Impact of refractory and unexplained chronic cough on disease burden: a qualitative study.

Authors:  Naoya Ueda; Anzu Yakushiji; Jonathan Schelfhout; Shigeru Tokita; Takekazu Kubo
Journal:  BMC Pulm Med       Date:  2022-10-01       Impact factor: 3.320

4.  Validation of the PROFAD-SSI-SF in Patients with Primary Sjögren's Syndrome with Organ Involvement: Results of Qualitative Interviews and Psychometric Analyses.

Authors:  Stephen Maher; Aaron Yarlas; Kimberly Raymond; Cory D Saucier; Meaghan O'Connor; Mark Kosinski; Wen-Hung Chen; Kerry Gairy
Journal:  Rheumatol Ther       Date:  2022-10-13

5.  Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis.

Authors:  Parambir S Dulai; Vipul Jairath; Reena Khanna; Christopher Ma; Kelly P McCarrier; Mona L Martin; Claire E Parker; Joan Morris; Brian G Feagan; William J Sandborn
Journal:  Aliment Pharmacol Ther       Date:  2020-04-21       Impact factor: 8.171

6.  Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings.

Authors:  Nina Galipeau; Brittany Klooster; Meaghan Krohe; Derek H Tang; Dennis A Revicki; David Cella
Journal:  J Patient Rep Outcomes       Date:  2019-02-07

7.  Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment.

Authors:  Joseph M Herman; Helen Kitchen; Arnold Degboe; Natalie V J Aldhouse; Andrew Trigg; Mary Hodgin; Amol Narang; Colin D Johnson
Journal:  Qual Life Res       Date:  2019-07-04       Impact factor: 4.147

8.  The Perspective of Physical Education Teachers in Spain Regarding Barriers to the Practice of Physical Activity among Immigrant Children and Adolescents: A Qualitative Study.

Authors:  Romain Marconnot; Jorge Pérez-Corrales; Juan Nicolás Cuenca-Zaldívar; Javier Güeita-Rodríguez; Pilar Carrasco-Garrido; Cristina García-Bravo; Eva Solera-Hernández; Sonia Gutiérrez Gómez-Calcerrada; Domingo Palacios-Ceña
Journal:  Int J Environ Res Public Health       Date:  2021-05-24       Impact factor: 3.390

9.  Family planning knowledge, experiences and reproductive desires among women who had experienced a poor obstetric outcome in Lilongwe Malawi: a qualitative study.

Authors:  Agatha Bula; Dawn M Kopp; Suzanne Maman; Lameck Chinula; Mercy Tsidya; Jennifer H Tang
Journal:  Contracept Reprod Med       Date:  2018-10-17

10.  Transgender Women's Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP).

Authors:  Christine Tagliaferri Rael; Javier Lopez-Ríos; Stacey A McKenna; Doyel Das; Curtis Dolezal; Elena Abascal; Alex Carballo-Diéguez; Rebecca Schnall; Thomas J Hope; José Bauermeister; Walter Bockting
Journal:  AIDS Behav       Date:  2021-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.